Ibrx investors have opportunity to lead immunitybio, inc. securities fraud lawsuit

Los angeles , july 31, 2023 /prnewswire/ -- the law offices of frank r. cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against immunitybio, inc. ("immunitybio" or the "company") (nasdaq: ibrx).

IBRX Ratings Summary

IBRX Quant Ranking